Tianhong (Zhejiang) Supply Chain Management Co., Ltd. Is a branch of Tianjin Hongri Pharmaceutical Co., Ltd. Tianjin Hongri Pharmaceutical Co., Ltd. Is a market value of more than 10 billion listed pharmaceutical enterprises. After more than 20 years of intensive treatment, the industry has become a high-tech pharmaceutical and health industry cluster that integrates investment and financing, production, research and development, and sales across many fields, such as traditional Chinese medicine formula granules, finished medicine, pharmaceutical excipients and raw materials, medical devices, medical treatment and health management services. Subordinate companies more than 50, with more than 6000 employees. In recent years, enterprises have continuously won many honors, such as national key high-tech enterprises, national enterprise technology center, national demonstration enterprise of technological innovation, national local joint engineering research center and so on. Since 2015, it has been ranked among the top 100 pharmaceutical industries in China. Scientific and technological innovation is the core driving force for the sustainable development of Hongri pharmaceutical industry. Enterprises have earlier built technology transformation centers, academician workstations, and established innovation alliances with the vast number of scientific research institutes, relying on scientific research technology to realize the dream of industrialization of scientific research results, which is beneficial to the people. Red day pharmaceutical industry has focused on critical, anti-tumor, cardiovascular and cerebrovascular, respiratory system, neurodegenerative five major drug areas of innovative research for many years, dedicated to reducing the mortality rate of ICU in China, has formed a group of critical care drugs such as Xuebijing ® Injection as the representative of the killer products with independent intellectual property rights.